The Cambridge Monographs on Applied and Computational Mathematics publishes expositions on all aspects of applicable, numerical and computational mathematics. The series represents the growth in ...

This month, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated to recommend ribociclib (Kisqali) as a Category 1 preferred CDK4/6 inhibitor (CDK4/6i) ...

So with the opportunity to make my first monograph with Rizzoli I wanted to bring together all the work I’ve put out in the last decade and share some of the process.” Any readers will gain ...

Irish designer Simone Rocha has published a chic new tome Simone Rocha attends the Harper's Bazaar Art Party in partnership with Tiffany & Co. at Mark's Club on October 8, 2024 in London, England ...

The chart below provides highlights of key monograph updates made this month (not an inclusive list). Click on the name of the drugs to view the full monographs on eMPR.com.

Their research suggested that neoadjuvant therapy with a combination of ribociclib and letrozole could be an alternative to multi-drug neoadjuvant chemotherapy. The trial involved high risk ...

If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence, including those with node-negative disease, will be eligible for adjuvant treatment ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.